Literature DB >> 7021995

[Alanine as a nitrogen sparing and gluconeogenetic substrate in the postoperative state (author's transl)].

J Funovics, E Roth, F Mühlbacher, F Schulz, J Karner, K Schultis, E Ogris, A Fritsch.   

Abstract

UNLABELLED: An alanine infusion (90 mg/kg/h) for eight hours was administered to seven patients after cholecystectomy in order to investigate the influence of elevated plasma alanine levels on the postoperative metabolism. The following metabolites and hormone concentrations were analysed in plasma: glucose, urea, free fatty acids, ketone bodies, amino acids, insulin and glucagon. Compared to the pre-infusion values on the 1. postoperative day after an overnight fasting, the following changes were monitored. The plasma glucose concentrations reached a maximum after four hours of infusion (p less than 0.05). Of the amino acids, significant elevated levels were found for alanine (300%, p less than 0.001), glutamine (36%, p less than 0.05), and alpha-aminobutyrate (61%, p less than 0.01). The free fatty acids and ketone bodies concentrations decreased immediately after the onset of the infusion of alanine (p less than 0.05), the increased again during the last four hours of infusion. The secretion of insulin and also the secretion of glucagon were stimulated by the increased alanine levels. The stimulation of insulin reached a maximum after only five minutes, but the glucagon levels increased continuously until the end of the infusion. During the administration of alanine a nitrogen homeostasis was achieved, which was a significant improvement (p less than 0.001) when compared to saline infusions before and after the alanine infusion.
CONCLUSIONS: (1) Postoperative increased plasma levels of alanine stimulate gluconeogenesis and reduce the plasma levels of lipolytic metabolites. The induced stimulation of insulin and glucagon is dependent on the duration of the alanine infusion for during extended infusion of alanine the insulin stimulation diminishes while the glucagon secretion continuously increases. (2) Alanine is a potent anabolic substrate in the immediate postoperative situation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021995     DOI: 10.1007/bf01724686

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  28 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

Review 2.  The glucose-alanine cycle.

Authors:  P Felig
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

3.  Intravenous glucose-tolerance, insulin, and free-fatty-acid levels in burned patients.

Authors:  S P Allison; P Hinton; M J Chamberlain
Journal:  Lancet       Date:  1968-11-23       Impact factor: 79.321

4.  Effect of fasting on alanine-stimulated insulin and glucagon secretion.

Authors:  M T Buckman; M J Conway; J A Seibel; R P Eaton
Journal:  Metabolism       Date:  1973-10       Impact factor: 8.694

5.  Free amino acids in plasma in the post-traumatic period.

Authors:  R Dölp; W Fekl; W Ahnefeld
Journal:  Infusionsther Klin Ernahr       Date:  1975-10

6.  The origin of alanine produced in skeletal muscle.

Authors:  T W Chang; A L Goldberg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

7.  Fasting metabolism in infants: II. The effect of severe undernutrition and infusion of alanine on glucose production estimated with U-13C-glucose.

Authors:  D S Kerr; M C Stevens; D I Picou
Journal:  Metabolism       Date:  1978-07       Impact factor: 8.694

8.  Plasma insulin and surgery. I. Early changes due to operation in the insulin response to glucose.

Authors:  A E Giddings; D Mangnall; B J Rowlands; R G Clark
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

9.  Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal.

Authors:  S Rubenfeld; A J Garber
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Insulin to inhibit protein catabolism after injury.

Authors:  A M Woolfson; R V Heatley; S P Allison
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.